- Centers for Disease Control and Prevention (CDC). Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46(RR-8):1–24.
View all references
- Centers for Disease Control and Prevention (CDC). Active Bacterial Core Surveillance (ABCs) Report: Emerging Infections Program Network: Streptococcus pneumoniae, 2009. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services; 2009.
View all references
- Kyaw MH, Rose CE Jr, Fry AM, et al; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis. 2005;192(3):377–386.
View all references
- Centers for Disease Control and Prevention (CDC). Pneumococcal disease. In: Atkinson W, Wolfe C, Hamborsky J, et al, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 12th rev ed. Washington, DC: Public Health Foundation; 2011:233–248.
View all references
- American Diabetes Association (ADA). Immunization and the prevention of influenza and pneumococcal disease in people with diabetes. Diabetes Care. 2000;23(1):109–111.
View all references
- Siddiqi A, Sethi S. Optimizing antibiotic selection in treating COPD exacerbations. Int J Chron Obstruct Pulmon Dis. 2008;3(1):31–44.
View all references
- Pilishvili T, Lexau C, Farley MM, et al; Active Bacterial Core Surveillance/Emerging Infections Program Network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201(1):32–41.
View all references
- Regev-Yochay G, Raz M, Dagan R, et al. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis. 2004;38(5):632−639.
View all references
- Goldblatt D, Hussain M, Andrews N, et al. Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J Infect Dis. 2005;192(3):387−393.
View all references
- McCormick AW, Whitney CG, Farley MM, et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med. 2003;9(4):424–430.
View all references
- Inostroza J, Vinet AM, Retamal G, et al. Influence of patient age on Streptococcus pneumoniae serotypes causing invasive disease. Clin Diagn Lab Immunol. 2001;8(3):556–559.
View all references
- Jansen AGSC, Rodenburg GD, van der Ende A, et al. Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. Clin Infect Dis. 2009;49(2):e23–e29.
View all references
- Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases—United States, 2008. MMWR Morb Mortal Wkly Rep. 2010;57(54):1–94.
View all references
- National Foundation for Infectious Diseases (NFID). Facts about pneumococcal disease. http://www.nfid.org/factsheets
/pneumofacts.shtml. Published October 2002. Accessed August 29, 2011.
View all references
- Centers for Disease Control and Prevention (CDC). Drug-resistant Streptococcus pneumoniae disease. http://www.cdc.gov
/ncidod/dbmd/diseaseinfo
/drugresisstreppneum_t.htm. Updated May 25, 2010. Accessed August 29, 2011.
View all references
- Regev-Yochay G, Raz M, Dagan R, et al. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis. 2004;38(5):632−639.
- Goldblatt D, Hussain M, Andrews N, et al. Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J Infect Dis. 2005;192(3):387−393.
- McCormick AW, Whitney CG, Farley MM, et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med. 2003;9(4):424–430.
Pneumococcal_ToolTipContent
|
|
